Richard P Baum Selected Research

Peptide Receptors (Peptide Receptor)

11/2021	First-in-Humans Study of the SSTR Antagonist 177Lu-DOTA-LM3 for Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Neoplasms: Dosimetry, Safety, and Efficacy.
1/2021	Prior Resection of the Primary Tumor Prolongs Survival After Peptide Receptor Radionuclide Therapy of Advanced Neuroendocrine Neoplasms.
11/2020	Prognostic Value of 18F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy.
5/2020	177Lu-DOTATOC Peptide Receptor Radionuclide Therapy in a Patient With Neuroendocrine Breast Carcinoma and Breast Invasive Ductal Carcinoma.
4/2020	Twelve-Year Survival of a Patient With Lymph Node, Pulmonary, Bone, Cardiac and Intraspinal Metastases of a Rectal Neuroendocrine Neoplasm Treated With Peptide Receptor Radionuclide Therapy-The Value of Salvage Peptide Receptor Radionuclide Therapy.
3/2020	Peptide Receptor Radionuclide Therapy Using 225Ac-DOTATOC Achieves Partial Remission in a Patient With Progressive Neuroendocrine Liver Metastases After Repeated β-Emitter Peptide Receptor Radionuclide Therapy.
3/2020	Successful Intra-arterial Peptide Receptor Radionuclide Therapy of DOTATOC-Negative High-Grade Liver Metastases of a Pancreatic Neuroendocrine Neoplasm Using 177Lu-DOTA-LM3: A Somatostatin Receptor Antagonist.
2/2020	Ectopic Corticotropin-Releasing Hormone-Secreting Pancreatic Neuroendocrine Tumor: Excellent Response of Liver Metastases to Peptide Receptor Radionuclide Therapy as Demonstrated by 68Ga-DOTATOC and 18F-FDG PET/CT Imaging.
1/2020	PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest.
12/2019	Metastatic Nasopharyngeal Carcinoma Treated With Intraarterial Combined With Intravenous Peptide Receptor Radionuclide Therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard P Baum Research Topics

Disease

64	Neoplasms (Cancer) 01/2022 - 01/2003
31	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2021 - 07/2006
28	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2010
23	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 08/2015
3	Diarrhea 03/2021 - 01/2018
3	Breast Neoplasms (Breast Cancer) 05/2020 - 06/2010
3	Thyroid Neoplasms (Thyroid Cancer) 01/2018 - 01/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2015 - 01/2003
2	Adenocarcinoma 01/2022 - 01/2018
2	Thrombocytopenia (Thrombopenia) 11/2021 - 12/2017
2	Lymphatic Metastasis 05/2020 - 01/2003
2	Carcinoid Tumor (Carcinoid) 05/2019 - 02/2015
2	Pain (Aches) 01/2018 - 03/2015
2	Disease Progression 12/2017 - 01/2012
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2017 - 05/2016
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2016 - 01/2010
2	Paraganglioma (Paragangliomas) 07/2015 - 07/2006
2	Pheochromocytoma 06/2012 - 07/2006
1	Sialorrhea 01/2022
1	Anemia 11/2021
1	Leukopenia 11/2021
1	Flushing 03/2021
1	Abdominal Pain (Pain, Abdominal) 03/2021
1	Ductal Carcinoma 05/2020
1	Cushing Syndrome 02/2020
1	Bone Diseases (Bone Disease) 01/2020
1	Nasopharyngeal Carcinoma 12/2019
1	Solitary Kidney 11/2019
1	Lymphedema (Milroy Disease) 06/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2018
1	Leukemia 03/2018
1	Fatigue 01/2018
1	Neutropenia 12/2017
1	Lymphopenia (Lymphocytopenia) 12/2017

Drug/Important Bio-Agent (IBA)

41	Radioisotopes (Radionuclides)IBA 01/2022 - 12/2009
37	Peptide Receptors (Peptide Receptor)IBA 11/2021 - 07/2006
30	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2021 - 07/2006
17	AntigensIBA 01/2022 - 07/2003
17	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2021 - 07/2006
10	Peptides (Polypeptides)IBA 01/2022 - 01/2012
9	Edotreotide (SMT 487)IBA 05/2020 - 01/2013
8	LigandsIBA 07/2019 - 07/2006
4	lutetium Lu 177 dotatateIBA 03/2021 - 12/2017
4	PSMA-617IBA 11/2019 - 01/2017
4	edotreotide lutetium LU-177IBA 01/2013 - 01/2013
3	177Lu-PSMA-617IBA 01/2022 - 01/2017
3	RadiopharmaceuticalsIBA 11/2021 - 07/2006
3	Octreotide (Sandostatin)FDA LinkGeneric 03/2021 - 12/2013
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 03/2020 - 06/2007
3	PSMA I&TIBA 07/2019 - 08/2015
3	Chemokine ReceptorsIBA 01/2019 - 02/2015
3	IodineIBA 01/2018 - 01/2013
3	Bombesin Receptors (Bombesin Receptor)IBA 07/2017 - 05/2016
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2012
2	DOTA(0)-Tyr(3)- 177Lu-octreotideIBA 11/2021 - 05/2020
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2020 - 02/2020
2	Hormones (Hormone)IBA 02/2020 - 05/2019
2	gallium 68 PSMA-11IBA 07/2019 - 08/2015
2	Alkaline PhosphataseIBA 07/2019 - 01/2017
2	Monoclonal AntibodiesIBA 01/2019 - 07/2003
2	Gallium-68IBA 01/2019 - 02/2012
2	Lutetium-177IBA 01/2019 - 12/2017
2	Diphosphonates (Bisphosphonates)IBA 05/2017 - 04/2010
2	Glucose (Dextrose)FDA LinkGeneric 10/2012 - 01/2010
2	3-Iodobenzylguanidine (Iobenguane)IBA 12/2010 - 07/2006
2	Deoxyglucose (2 Deoxy D glucose)IBA 01/2010 - 02/2003
2	pentetreotide (OctreoScan)FDA Link 07/2008 - 07/2007
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2022
1	incobotulinumtoxinA FDA Link 01/2022
1	68Ga-FAPIIBA 01/2022
1	Proteasome InhibitorsIBA 01/2021
1	Bortezomib (Velcade)FDA Link 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 11/2020
1	B7-H1 AntigenIBA 11/2020
1	Ga(III)-DOTATOCIBA 02/2020
1	Corticotropin-Releasing HormoneIBA 02/2020
1	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2020
1	Investigational DrugsIBA 01/2020
1	taxaneIBA 07/2019
1	Hemoglobins (Hemoglobin)IBA 07/2019
1	PowdersIBA 05/2019
1	ZeolitesIBA 05/2019
1	Serotonin (5 Hydroxytryptamine)IBA 05/2019
1	Yttrium-90IBA 01/2019
1	Neurotensin Receptors (Neurotensin Receptor)IBA 01/2018
1	GadoliniumIBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	gadolinium ethoxybenzyl DTPA FDA Link 01/2018
1	BombesinIBA 07/2017

Therapy/Procedure

68	Therapeutics 01/2022 - 01/2003
15	Castration 01/2022 - 08/2015
14	Precision Medicine 01/2021 - 01/2012
12	Radiotherapy 01/2020 - 01/2003
7	Drug Therapy (Chemotherapy) 11/2021 - 01/2003
4	Aftercare (After-Treatment) 11/2021 - 01/2016
1	Injections 01/2022
1	Renal Dialysis (Hemodialysis) 03/2018
1	Intravenous Infusions 12/2017